PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16200342-2	2006	Targeting with radionuclide labelled substances that bind specifically to the epidermal growth factor receptor, EGFR, is considered for intracavitary therapy of EGFR-positive glioblastoma multiforme, GBM.	Radioisotopes	15-27	epidermal growth factor receptor	Homo sapiens	78-110	
16200342-2	2006	Targeting with radionuclide labelled substances that bind specifically to the epidermal growth factor receptor, EGFR, is considered for intracavitary therapy of EGFR-positive glioblastoma multiforme, GBM.	Radioisotopes	15-27	epidermal growth factor receptor	Homo sapiens	112-116	
16200342-2	2006	Targeting with radionuclide labelled substances that bind specifically to the epidermal growth factor receptor, EGFR, is considered for intracavitary therapy of EGFR-positive glioblastoma multiforme, GBM.	Radioisotopes	15-27	epidermal growth factor receptor	Homo sapiens	161-165